For bacterial tonsillitis, which oral antibiotic is preferred: cephalexin or cefdinir?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cephalexin is Preferred Over Cefdinir for Bacterial Tonsillitis

For bacterial tonsillitis caused by Group A Streptococcus (GAS), penicillin V remains the first-line treatment, but when a cephalosporin is indicated, cephalexin is the preferred choice over cefdinir. 1, 2, 3

Guideline-Based Recommendations

The 2012 IDSA guidelines for Group A streptococcal pharyngitis do not specifically recommend cephalosporins as first-line therapy 1. The European guideline for acute sore throat similarly emphasizes penicillin V (twice or three times daily for 10 days) as the recommended first-line agent 2. However, when cephalosporins are considered, first-generation agents like cephalexin are the appropriate choice 4.

Why Cephalexin Over Cefdinir

FDA Indications and Labeling

  • Cephalexin is FDA-approved for pharyngitis/tonsillitis caused by Streptococcus pyogenes 3
  • Cefdinir is also FDA-approved for this indication 5
  • However, both labels note that only intramuscular penicillin has been proven to prevent rheumatic fever 5, 3

Clinical Efficacy Evidence

While meta-analyses show cephalosporins achieve slightly higher bacteriologic cure rates than penicillin (OR 1.47-1.83), the clinical differences are small and not clinically relevant 2, 6. A 1992 study directly comparing cephalexin to penicillin showed cephalexin had lower treatment failure rates (10% vs 19% combined clinical and bacteriologic failure) 7.

Practical Considerations

Cephalexin advantages:

  • First-generation cephalosporin with narrower spectrum (reduces collateral damage to normal flora)
  • Lower cost
  • Well-established track record for streptococcal infections
  • Appropriate spectrum targeting GAS without unnecessary broad coverage 2, 4

Cefdinir concerns:

  • Third-generation agent with unnecessarily broad spectrum for simple GAS tonsillitis
  • More expensive
  • Recent evidence shows concerning treatment failures in urinary tract infections, with higher rates of subsequent cephalosporin resistance 8, 9
  • Should be reserved for more resistant organisms or specific indications

When Cephalosporins Are Indicated

Cephalosporins (specifically cephalexin) may be preferred over penicillin in these situations:

  • Penicillin treatment failure
  • Frequent recurrences requiring more reliable GAS eradication
  • Penicillin allergy (though macrolides are also appropriate alternatives) 4

Dosing Recommendations

Cephalexin:

  • Adults: 500 mg twice daily for 10 days
  • Pediatrics: 25-50 mg/kg/day divided doses for 10 days 3, 7

Critical Caveat

Neither cephalexin nor cefdinir has been proven to prevent rheumatic fever following streptococcal pharyngitis—only intramuscular penicillin has this evidence. If rheumatic fever prevention is the primary concern, intramuscular benzathine penicillin G remains the gold standard 1, 5, 3.

References

Guideline

guideline for the management of acute sore throat.

Clinical Microbiology and Infection, 2012

Research

Clinical practice guideline: tonsillitis I. Diagnostics and nonsurgical management.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2016

Research

Meta-analysis of cephalosporins versus penicillin for treatment of group A streptococcal tonsillopharyngitis in adults.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004

Research

Cefdinir vs cephalexin for the treatment of urinary tract infections: A retrospective evaluation.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.